About This Event
Generate:Biomedicines (Nasdaq: GENB), a clinical-stage generative biology company pioneering the AI revolution in drug design and development, visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, Mike Nally, Chief Executive Officer rings the Opening Bell.